State Street Corp Alector, Inc. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Alector, Inc. stock. As of the latest transaction made, State Street Corp holds 2,616,809 shares of ALEC stock, worth $9.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,616,809

Previous 2,789,877 6.2%

Holding current value

$9.53 Million

Previous $12.7 Million 3.52%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.34 - $6.58 $751,115 - $1.14 Million	-173,068 Reduced 6.2%	2,616,809 $12.2 Million
Q2 2024 Aug 14, 2024	SELL	$4.19 - $6.23 $4.71 Million - $7.01 Million	-1,125,292 Reduced 28.74%	2,789,877 $12.7 Million
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $4.54 Million - $6.44 Million	797,640 Added 25.59%	3,915,169 $23.6 Million
Q4 2023 Feb 14, 2024	BUY	$3.77 - $8.39 $1.06 Million - $2.36 Million	280,822 Added 9.9%	3,117,529 $24.9 Million
Q3 2023 Nov 14, 2023	BUY	$5.2 - $8.77 $611,312 - $1.03 Million	117,560 Added 4.32%	2,836,707 $18.4 Million
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $4.96 Million - $6.71 Million	-846,184 Reduced 23.73%	2,719,147 $16.3 Million
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $1.96 Million - $3.3 Million	335,814 Added 10.4%	3,565,331 $22.1 Million
Q4 2022 Feb 14, 2023	SELL	$6.88 - $9.55 $440,870 - $611,964	-64,080 Reduced 1.95%	3,229,517 $29.8 Million
Q3 2022 Nov 15, 2022	SELL	$8.19 - $13.2 $5.08 Million - $8.19 Million	-620,739 Reduced 15.86%	3,293,597 $31.2 Million
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $598,558 - $1.11 Million	78,243 Added 2.04%	3,914,336 $39.8 Million
Q1 2022 May 16, 2022	BUY	$13.02 - $20.78 $10.1 Million - $16.1 Million	772,398 Added 25.21%	3,836,093 $54.7 Million
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $10.1 Million - $13.3 Million	-520,824 Reduced 14.53%	3,063,695 $63.3 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $18.3 Million - $33.3 Million	843,189 Added 30.76%	3,584,519 $81.8 Million
Q2 2021 Aug 16, 2021	BUY	$15.5 - $22.48 $437,627 - $634,700	28,234 Added 1.04%	2,741,330 $57.1 Million
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $5.02 Million - $7.52 Million	-338,435 Reduced 11.09%	2,713,096 $54.6 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $5.03 Million - $8.93 Million	-534,865 Reduced 14.91%	3,051,531 $46.2 Million
Q3 2020 Nov 10, 2020	BUY	$10.54 - $24.96 $18.7 Million - $44.3 Million	1,776,001 Added 98.1%	3,586,396 $37.8 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $14.8 Million - $22.4 Million	676,606 Added 59.68%	1,810,395 $44.2 Million
Q1 2020 May 11, 2020	BUY	$16.25 - $35.28 $18.4 Million - $40 Million	1,133,789 New	1,133,789 $27.4 Million

Others Institutions Holding ALEC

# of Institutions

167

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $301M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Alector, Inc. Transaction History